Clinical Trial Update: Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype [Phase 2]

View source ↗

Summary

Phase 2 study evaluating nemtabrutinib combined with pembrolizumab for Richter transformation and Diffuse Large B-Cell Lymphoma in patients with Chronic Lymphoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Richter Syndrome

Drugs mentioned

• Nemtabrutinib (nemtabrutinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Richter Syndrome, Diffuse Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING